1-3 of 3
Jürgen Scheele
Close
Sort by
Journal Articles

CD19/CD3 Bispecific Antibody Blinatumomab (MT-103) Is Highly Effective In Treatment of Patients with Minimal Residual Disease From Chemotherapy-Resistant B-Precursor Acute Lymphoblastic Leukemia

Max S Topp, Gerhard Zugmaier, MD, Nicola Goekbuget, MD, Svenja Neumann, MD, Heinz-August Horst, MD, Thorsten Raff, MD, Monika Brueggemann, MD, Michael Kneba, MD, Andreas Viardot, MD, Mathias Schmid, MD, Markus Schaich, MD, Matthias Stelljes, MD, Mariele Goebeler, MD, Heike Pfeiffer, MD, Oliver Ottmann, MD, Thomas Burmeister, MD, Evelyn Degenhard, Margit Schmidt, PhD, Jürgen Scheele, MD, PhD, Hermann Einsele, MD, Peter Kufer, MD, Matthias Klinger, PhD, Dirk Nagorsen, MD, Dieter Hoelzer, MD, Ralf Bargou, MD
Journal: Blood
Blood (2010) 116 (21): 174.
https://doi.org/10.1182/blood.V116.21.174.174
Published: 2010
Journal Articles

Mesenchymal Stromal Cells (MSCs) Lack Adhesion to Endothelial Cells through Selectins and b2 Integrins and Interact Dominantly Using Integrin a4b1 Activated by GTPase Rap1.

Olga Nilmaer, Melanie Giesen, Erika Deak, Victoria Lang, Johannes Leibacher, Lisa Keller, Felicia Ciuculescu, Kate Kollar, Annete Dorn, Jürgen Scheele, Tanja Nicole Hartmann, Reinhard Henschler
Journal: Blood
Blood (2010) 116 (21): 2589.
https://doi.org/10.1182/blood.V116.21.2589.2589
Published: 2010
Journal Articles

The Small GTPase Rap1A Is Central for Migration and Adhesion of Mesenchymal Stromal Cells (MSCs)

Erika Deak, Brigitte Ruester, Stephan Göttig, Elena Puccetti, Ph.D., Martin Ruthardt, MD, Erhard Seifried, MD, PhD, Jürgen Scheele, MD, Reinhard Henschler
Journal: Blood
Blood (2008) 112 (11): 2426.
https://doi.org/10.1182/blood.V112.11.2426.2426
Published: 2008